Singapore markets closed

PROCEPT BioRobotics Corporation (PRCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
17.31-1.04 (-5.67%)
At close: 04:00PM EST
16.50 -0.81 (-4.68%)
After hours: 04:09PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 1.29B
Enterprise value 1.02B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)46.73
Price/book (mrq)4.55
Enterprise value/revenue 37.10
Enterprise value/EBITDA -21.58

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-58.73%
S&P500 52-week change 314.07%
52-week high 347.73
52-week low 317.27
50-day moving average 329.73
200-day moving average 334.80

Share statistics

Avg vol (3-month) 3188.83k
Avg vol (10-day) 3259.23k
Shares outstanding 543.5M
Implied shares outstanding 6N/A
Float 836.22M
% held by insiders 16.32%
% held by institutions 162.75%
Shares short (30 Dec 2021) 41.35M
Short ratio (30 Dec 2021) 45.18
Short % of float (30 Dec 2021) 48.68%
Short % of shares outstanding (30 Dec 2021) 43.10%
Shares short (prior month 29 Nov 2021) 4310.75k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin -206.06%
Operating margin (ttm)-183.41%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)27.56M
Revenue per share (ttm)4.12
Quarterly revenue growth (yoy)311.40%
Gross profit (ttm)-1.25M
EBITDA -47.26M
Net income avi to common (ttm)-56.78M
Diluted EPS (ttm)-8.49
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)320.48M
Total cash per share (mrq)7.37
Total debt (mrq)55.8M
Total debt/equity (mrq)19.70
Current ratio (mrq)23.94
Book value per share (mrq)6.52

Cash flow statement

Operating cash flow (ttm)-54.3M
Levered free cash flow (ttm)N/A